Department of Surgery, Cooper University Health Care, Ste 411, 3 Cooper Plaza, Camden, NJ, 08103, USA.
Department of Statistics, University of Connecticut, Storrs, CT, USA.
Int J Colorectal Dis. 2023 Apr 25;38(1):109. doi: 10.1007/s00384-023-04392-y.
Treatment of invasive rectal adenocarcinoma is stratified into upfront surgery versus neoadjuvant chemoradiotherapy, in part, based on tumor distance from the anal verge (AV). This study examines the correlation between tumor distance measurements (endoscopic and MRI) and relationship to the anterior peritoneal reflection (aPR) on MRI.
A single-center retrospective study was performed at a tertiary center accredited by the National Accreditation Program for Rectal Cancer (NAPRC). 162 patients with invasive rectal cancer were seen between October of 2018 and April of 2022. Sensitivity and specificity were determined for MRI and endoscopic measurements in their ability to predict tumor location relative to the aPR.
One hundred nineteen patients had tumors endoscopically and radiographically measured from the AV. Pelvic MRI characterized tumors as above (intraperitoneal) or at/straddles/below the aPR (extraperitoneal). True positives were defined as extraperitoneal tumors [Formula: see text] 10 cm. True negatives were defined as intraperitoneal tumors > 10 cm. Endoscopy was 81.9% sensitive and 64.3% specific in predicting tumor location with respect to the aPR. MRI was 86.7% sensitive and 92.9% specific. Utilizing a 12 cm cutoff, sensitivity of both modalities increased (94.3%, 91.4%) but specificity decreased (50%, 64.3%).
For locally invasive rectal cancers, tumor position relative to the aPR is an important factor in determining the role of neoadjuvant therapy. These results suggest endoscopic tumor measurements do not accurately predict tumor location relative to the aPR, and may lead to incorrect treatment stratification recommendation. When the aPR is not identified, MRI-reported tumor distance may be a better predictor of this relationship.
侵袭性直肠腺癌的治疗分为直接手术与新辅助放化疗,部分依据肿瘤距肛缘(AV)的距离。本研究旨在探讨肿瘤距离测量(内镜和 MRI)与 MRI 上前腹膜反射(aPR)的相关性。
本研究为单中心回顾性研究,在一家经国家直肠癌认证计划(NAPRC)认证的三级中心进行。2018 年 10 月至 2022 年 4 月期间,共纳入 162 例侵袭性直肠腺癌患者。评估 MRI 和内镜测量在预测肿瘤相对于 aPR 的位置方面的准确性,计算敏感度和特异度。
119 例患者的肿瘤经内镜和影像学测量距 AV。盆腔 MRI 将肿瘤分为腹膜内(位于或跨越 aPR)或腹膜外(低于 aPR)。真阳性定义为腹膜外肿瘤距 aPR<10cm,真阴性定义为腹膜内肿瘤距 aPR>10cm。内镜预测肿瘤相对于 aPR 的位置的敏感度为 81.9%,特异度为 64.3%。MRI 的敏感度为 86.7%,特异度为 92.9%。当使用 12cm 截断值时,两种方法的敏感度均升高(94.3%、91.4%),但特异度降低(50%、64.3%)。
对于局部侵袭性直肠腺癌,肿瘤相对于 aPR 的位置是决定新辅助治疗作用的重要因素。这些结果表明,内镜下肿瘤测量不能准确预测肿瘤相对于 aPR 的位置,可能导致治疗分层推荐错误。当无法识别 aPR 时,MRI 报告的肿瘤距离可能是更好的预测因素。